scispace - formally typeset
S

Scott C. Miller

Researcher at University of Utah

Publications -  259
Citations -  8243

Scott C. Miller is an academic researcher from University of Utah. The author has contributed to research in topics: Cancellous bone & Bone remodeling. The author has an hindex of 52, co-authored 258 publications receiving 7925 citations. Previous affiliations of Scott C. Miller include University of Nebraska Medical Center & Harvard University.

Papers
More filters
Journal ArticleDOI

Expression and signal transduction of calcium-sensing receptors in cartilage and bone.

Wenhan Chang, +7 more
- 01 Dec 1999 - 
TL;DR: In this paper, the effects of CaR agonists on signal transduction in chondrogenic and osteogenic cell lines were investigated and the results supported the concept that changes in [Ca 21 ] may couple to signaling pathways important in skeletal metabolism.
Journal ArticleDOI

Bone-targeting macromolecular therapeutics.

Dong Wang, +3 more
- 25 May 2005 - 
TL;DR: Bone-targeting drug delivery systems based on water-soluble polymers can specifically direct candidate drugs to bone thereby reducing side effects due to non-specific tissue interactions.
Journal ArticleDOI

Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems

Dong Wang, +4 more
- 20 Aug 2003 - 
TL;DR: Four polymeric bone-targeting conjugates were synthesized based on poly(ethylene glycol) (PEG) and poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA) and indicated that these novel delivery systems could specifically accumulate in the bone tissue.
Journal ArticleDOI

Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus.

Jenny Heap, +4 more
- 01 Jan 2004 - 
TL;DR: Altered bone mineral acquisition in adolescents with type 1 DM may limit peak bone mass acquisition and increase the risk of osteoporosis in later life.
Journal ArticleDOI

Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis

Dong Wang, +8 more
- 18 Jan 2007 - 
TL;DR: A novel pH-sensitive drug delivery system based on an N-(2-hydroxypropyl)methacrylamide copolymer (P-Dex) provides a unique method for selective targeting of glucocorticoids to inflamed joints which may potentially reduce systemic side effects.